Now that Extreme E is on a hiatus while it turns into Extreme H, and World Rallycross has switched to a competition between EVs and combustion, Formula E is back to being the primary fully ...
In June 2021, the Food and Drug Administration approved aducanumab, an amyloid beta-targeted drug, under the “accelerated approval” program for patients diagnosed with Alzheimer’s.
2 This followed the controversial approval of aducanumab (Aduhelm; Biogen), which the FDA granted an accelerated approval in 2021 despite the lack of a recommendation from the FDA advisory committee.
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...
The report was prompted by the FDA's 2021 approval of the Alzheimer's disease drug aducanumab (Aduhelm) using the accelerated approval pathway. The aducanumab approval raised concerns in Congress ...
In nearly 20 years, aside from cholinesterase inhibitors, memantine is the only drug approved for the treatment of Alzheimer's disease (AD). Memantine is an uncompetitive N-methyl-D-aspartate ...
Formula E is back for Round 2 after a classic season-opener in Sao Paulo. Mexico City is next on the schedule and is a favourite of fans and drivers alike, with what's likely to be another sell-out ...
Leveraging a roster of innovative technical upgrades, the GEN3 Evo unveiled at H.S.H Prince Albert II’s Private Car Collection will debut in Season 11 of the ABB FIA Formula E World Championship.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback